Vital Signs - Market Implications of the $1000 Genome: An Evolving Competitive Landscape
Vital Signs - Market Implications of the $1000 Genome: An Evolving Competitive Landscape
RELEASE DATE
03-Mar-2008
03-Mar-2008
REGION
North America
North America
Research Code: 9561-00-57-00-00
SKU: HC00518-NA-MR_03990
$1,500.00
In stock
SKU
HC00518-NA-MR_03990
Description
This issue of Vital Signs, released on March 3, 2008, provides an strategic overview of market implications of the $1000 Genome. Additionally, a company spotlight is provided for Pacific Biosciences, a biotechnology company developing a transformative single-molecule, real-time (SMRT) DNA sequencing platform. Reimbursement and regulatory news from the FDA is also provided for the week of February 18 - February 22, 2008.
Table of Contents
This week's issue:
Popular Topics
residential energy storage market
plastic waste management market
electric vehicle market analysis
This issue of Vital Signs, released on March 3, 2008, provides an strategic overview of market implications of the $1000 Genome. Additionally, a company spotlight is provided for Pacific Biosciences, a biotechnology company developing a transformative single-molecule, real-time (SMRT) DNA sequencing platform. Reimbursement and regulatory news from the FDA is also provided for the week of February 18 - February 22, 2008.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-57-00-00 |
Is Prebook | No |